从历年GOLD中慢性阻塞性肺疾病的定义探讨对其本质的认识

doi:10.16138/j.1673-6087.2024.05.01

内科理论与实践 ›› 2024, Vol. 19 ›› Issue (05): 289-294.doi: 10.16138/j.1673-6087.2024.05.01

• 专家论坛 • 下一篇

从历年GOLD中慢性阻塞性肺疾病的定义探讨对其本质的认识

何权瀛

北京大学人民医院呼吸与危重症医学科，北京 100044

收稿日期:2024-05-07 出版日期:2024-10-28 发布日期:2025-01-16

Discussion on understanding of the essence of chronic obstructive pulmonary disease from the definitions of chronic obstructive pulmonary disease in GOLD over the years

HE Quanying

Department of Respiratory and Critical Care Medicine， Peking University People’s Hospital, Beijing 100044, China

Received:2024-05-07 Online:2024-10-28 Published:2025-01-16

摘要/Abstract

摘要：

本文从复习历年来慢性阻塞性肺疾病（chronic obstructive pulmonary disease，COPD）全球创议（Global Initiative for Chronic Obstructive Lung Disease，GOLD）对COPD的定义出发，从中可见对于COPD本质的认识逐渐深化和全面。但是必须承认对于COPD的定义仍存在某些不足之处，包括气道炎症、发病病因、疾病异质性等方面，最后强调COPD的共病诊断和干预，需要多学科协作。

关键词: GOLD, 慢性阻塞性肺疾病, 共病

Abstract:

This article reviewed the definition of chronic obstructive pulmonary disease (COPD) in Global Initiative for Chronic Obstructive Lung Disease (GOLD) over the years, from which it can be seen that our understanding of the nature of COPD has gradually deepened and comprehensively. However, there are still some deficiencies in definition of COPD, including airway inflammation, etiology, disease heterogeneity, etc. The comorbid diagnosis and intervention of COPD requires multidisciplinary collaboration.

Key words: Global Initiative for Chronic Obstructive Lung Disease, Chronic obstructive pulmonary disease, Multimorbidity

中图分类号:

R563

何权瀛. 从历年GOLD中慢性阻塞性肺疾病的定义探讨对其本质的认识[J]. 内科理论与实践, 2024, 19(05): 289-294.

HE Quanying. Discussion on understanding of the essence of chronic obstructive pulmonary disease from the definitions of chronic obstructive pulmonary disease in GOLD over the years[J]. Journal of Internal Medicine Concepts & Practice, 2024, 19(05): 289-294.

参考文献 12

[1]	GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2001, 163(5):1256-1276.
[2]	GOLD Scientific Committee. Guideline for the management of chronic obstructive pulmonary disease-2011 update[J]. 2011,S Afr Med J, 2011, 101(1 Pt 2):63-73.
[3]	GOLD Scientific Committee. Global strategy for diagnosis, management, and prevention of COPD-2016[EB/OL]. 2016. https://goldcopd.org/%20global-strategy-diagnosis-management-prevention-copd-2016/.
[4]	GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care, 2013, 187(4):347-365.
[5]	GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease[EB/OL]. 2006. https://goldcopd.org/.
[6]	GOLD Scientific Committee. Gold 2017 global strategy for the diagnosis, management and prevention of COPD[EB/OL]. 2017. https://goldcopd.org/gold-2017-global-strategy-diagnosis-management-%20prevention-copd/.
[7]	GOLD Scientific Committee. 2020 global strategy for prevention, diagnosis and management of COPD[EB/OL]. 2020. https://goldcopd.org/gold-reports/.
[8]	GOLD Scientific Committee. 2022 global strategy for prevention, diagnosis and management of COPD[EB/OL]. 2022. https://goldcopd.org/2022-gold-reports/.
[9]	GOLD Scientific Committee. Global strategy for prevention, diagnosis and management of copd: 2023 report[EB/OL]. 2023. https://goldcopd.org/2023-gold-report-2/.
[10]	GOLD Scientific Committee Global strategy for prevention, diagnosis and management of copd: 2024 report[EB/OL]. 2024. https://goldcopd.org/2024-gold-report/.
[11]	何权瀛. 慢性阻塞性肺疾病(何权瀛2019观点)[M]. 北京: 科学技术文献出版社, 2019:6-20.
[12]	GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of COPD: 2003 update[J]. Eur Respir J, 2003, 22(1):1-2. doi: 10.1183/09031936.03.00063703 pmid: 12882441

[1]	强士豪, 戴晴霞, 黄丽娜, 郭华, 崔小川. 慢性阻塞性肺疾病合并阻塞性睡眠呼吸暂停的生物标志物研究进展[J]. 内科理论与实践, 2024, 19(05): 322-327.
[2]	刘杰, 张音, 许轶明, 任蕾, 沈宏华. 有氧训练对慢性阻塞性肺疾病合并阻塞性睡眠呼吸暂停患者的康复疗效[J]. 内科理论与实践, 2024, 19(05): 295-302.
[3]	赵雅洁, 何清, 徐志红. 肌少症对老年慢性阻塞性肺疾病患者生活质量及活动能力的影响[J]. 内科理论与实践, 2023, 18(06): 383-387.
[4]	王翠, 姜国刚, 崔晓利. 痰液分析对慢性阻塞性肺疾病诊疗及病情评估的研究进展[J]. 内科理论与实践, 2023, 18(05): 372-376.
[5]	常青, 陈宇清, 袁越阳, 张海, 李锋, 李兴旺. 压力控制通气时不同呼吸力学特性对吸气流量指数的影响[J]. 诊断学理论与实践, 2023, 22(05): 454-459.
[6]	孙娴雯, 李庆云. 关注保留比率的肺功能减损（PRISm）的慢性阻塞性肺疾病表型[J]. 诊断学理论与实践, 2023, 22(03): 234-237.
[7]	史玉玲, 陈文娟. 银屑病共病的现状及诊治[J]. 诊断学理论与实践, 2023, 22(03): 221-229.
[8]	沈宏华, 许轶明, 张音, 任蕾, 陈锐. 慢性阻塞性肺疾病-阻塞性睡眠呼吸暂停重叠综合征的研究进展[J]. 内科理论与实践, 2023, 18(02): 111-116.
[9]	张璐璐, 武倩男, 霍如婕, 田新瑞. 微RNA-206与肺部疾病的研究进展[J]. 内科理论与实践, 2022, 17(05): 413-417.
[10]	刘礼银, 胡系伟, 杨然. 远程医疗在慢性阻塞性肺疾病患者肺康复中的应用价值[J]. 内科理论与实践, 2022, 17(01): 97-101.
[11]	仇丽雯, 许轶明, 张音, 沈宏华, 陈慎. 抗阻联合有氧训练对老年慢性阻塞性肺疾病患者运动能力的疗效[J]. 内科理论与实践, 2022, 17(01): 78-83.
[12]	孙娴雯, 李庆云. 新型冠状病毒疫情时期的慢性阻塞性肺疾病管理策略——2022版慢性阻塞性肺疾病全球倡议解读[J]. 诊断学理论与实践, 2022, 21(01): 32-37.
[13]	黄丹, 陈崑. 银屑病相关流行病学调查进展[J]. 诊断学理论与实践, 2021, 20(01): 48-52.
[14]	李庆云, 孙娴雯. 慢性阻塞性肺疾病稳定期管理的几个新视点：2021版 GOLD指南解读[J]. 诊断学理论与实践, 2021, 20(01): 43-47.
[15]	李庆云, 孙娴雯. 细化稳定期COPD管理流程和随访策略：2020版GOLD指南解读[J]. 诊断学理论与实践, 2020, 19(04): 354-358.

从历年GOLD中慢性阻塞性肺疾病的定义探讨对其本质的认识

Discussion on understanding of the essence of chronic obstructive pulmonary disease from the definitions of chronic obstructive pulmonary disease in GOLD over the years

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 12

相关文章 15

编辑推荐

Metrics

本文评价